more

Centene (CNC)

(Delayed Data from NYSE)

$57.46 USD

-1.22 (-2.08%)

Updated Nov 15, 2024 04:00 PM ET

After-Market: $57.43 -0.03 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum C VGM

Industry Rank:

Top 33% (82 out of 250)

Industry: Medical - HMOs

View All Zacks #1 Ranked Stocks

Zacks News

Select Medical (SEM) Q1 Earnings Top on Improving Profitability

by Zacks Equity Research Published on May 05,2023

Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 billion.

Teladoc Health (TDOC) Shares Up 5% Since Q1 Earnings Release

by Zacks Equity Research Published on May 02,2023

Teladoc Health's (TDOC) Q1 results reflect solid chronic care product revenues and improving access fees and other revenues.

Molina Healthcare (MOH) Beats on Q1 Earnings, Ups '23 EPS View

by Zacks Equity Research Published on April 27,2023

Molina Healthcare's (MOH) Q1 results reflect strong performance in the Medicaid and Medicare segments. Meanwhile, the elevated expense level partially offset the positives.

Universal Health (UHS) Q1 Earnings Beat on Higher Admissions

by Zacks Equity Research Published on April 26,2023

Universal Health's (UHS) Q1 results reflect strong performance in acute care and behavioral health segments. Meanwhile, the elevated expense level partially offsets the positives.

Humana (HUM) Q1 Earnings Beat on Growing Membership & Premiums

by Zacks Equity Research Published on April 26,2023

Humana (HUM) expects adjusted EPS to be at least $28.25 in 2023, up from the previous guidance of $28 per share.

medical

Centene (CNC) Q1 Earnings Miss Estimates, '23 EPS View Raised

by Zacks Equity Research Published on April 25,2023

Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.

Centene (CNC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research Published on April 25,2023

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CNCNegative Net Change

Centene (CNC) Misses Q1 Earnings Estimates

by Zacks Equity Research Published on April 25,2023

Centene (CNC) delivered earnings and revenue surprises of -5.38% and 7.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Lower Managed Care Profits Hurt Centene's (CNC) Q1 Earnings?

by Zacks Equity Research Published on April 21,2023

Centene's (CNC) first-quarter results are likely to reflect growth in premiums and lower costs.

Here's Why You Should Retain Centene (CNC) in Your Portfolio

by Zacks Equity Research Published on April 11,2023

Strong membership growth, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

medical

Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?

by Zacks Equity Research Published on April 11,2023

Style Box ETF report for VOE

Why Centene (CNC) is a Top Value Stock for the Long-Term

by Zacks Equity Research Published on April 10,2023

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

CNCNegative Net Change

Centene (CNC) Expands Evolent Partnership to Boost Quality

by Zacks Equity Research Published on March 30,2023

Centene (CNC) expands the use of Evolent's oncology specialty care to improve cost management.

medical

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

by Zacks Equity Research Published on March 21,2023

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare

by Zacks Equity Research Published on March 20,2023

UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare are part of the Zacks Industry Outlook article.

5 HMO Stocks to Watch Despite Elevated Tech Costs, Nursing Shortage

by Debasmita Chatterjee Published on March 17,2023

Improved premiums cropping from a solid customer base might aid the Medical-HMO industry. However, an escalating expense level and an acute shortage of nurses are roadblocks. Stocks like UNH, CI, HUM, CNC and MOH are likely to navigate the industry storms.